Search Results 1141-1150 of 19340 for hemoglobin

1. A Study to Provide Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response - Mayo Clinic

   Chronic Anemia (hemoglobin of 10g per deciliter or less; Chronic gastrointestinal disorder (IBD, Celiac, etc.) Active cancer, chemotherapy or radiation ...

2. Joint Replacement Surgery Clinical Trials - Mayo Clinic Research

   We will collect both non-invasive hemoglobin and conventional serum hemoglobin labs from patients postoperatively following outpatient total joint ...

3. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

   Hemoglobin >= 9 mg/dL; Negative urine or serum pregnancy test performed =< 7 days prior to registration, for women of childbearing potential only; Previously ...

4. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope GFR ≥ 70 mL/min/1.73 m²; OR serum creatinine ...

5. A Study of the Effect of Dapagliflozin on Symptoms and Biomarkers in Diabetes Patients with Heart Failure - Mayo Clinic

   Hemoglobin A1c of 6.5-11.0% at enrollment; Established diagnosis of NYHA Class II or Class III heart failure (LVEF≤40% due to either ischemic or non ...

6. Publications - Sophie Bersoux, M.D., M.P.H. - Mayo Clinic

   Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes. Am J Clin Pathol. 2011 May; 135 (5):674-7. View PubMed; Bersoux S ...

7. Low blood oxygen (hypoxemia) - Mayo Clinic

   Hypoxemia is a low level of oxygen in the blood. It starts in blood vessels called arteries. Hypoxemia isn't an illness or a condition.

8. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   DLCO corrected for hemoglobin 30% to 79% of predicted, inclusive. Exclusion Criteria: History of acute exacerbation of IPF or respiratory tract infection ...

9. A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Urinalysis: No clinically significant abnormalities. Acceptable coagulation status: PT ≤ 1.5 times institutional ULN;; PTT ≤ 1.5 ...

10. A Study to Perform Synovial Biopsies on Patients with Rheumatoid Arthritis - Mayo Clinic

    Hemoglobin ≥ 9 g/dL; Platelets ≥ 100 x 109 cells/L. Able to adhere to the study visit schedule, understand and comply with other protocol requirements ...